상세검색
최근 검색어 삭제
다국어입력
즐겨찾기0
논문
 SCOPUS  SCIE  KCI등재 학술저널

A Practical Utility and Benefit of Pharmacogenetic-based Antidepressant Treatment Strategy for Major Depressive Disorder Patients with Difficult-to-treat

  • 이용수 0
155902.jpg

초록

Objective: We report the results of pharmacogenomics-based antidepressant treatment (PGXt) results in treating treatment- resistant major depressive disorder (TRD) patients in real practice. Methods: Nine patients were prescribed NeuropharmagenⓇ for selection of antidepressants for individual patient and their clinical outcomes were followed. Results: After treatment by PGXt results from current antidepressants, substantial reduction of depressive symptoms was observed at some point and maintained during observation period in six patients. Conclusion: Our case series potentially shows the clinical utility and benefit of PGXt for treatment of TRD patients.

목차

INTRODUCTION

METHODS

RESULTS

DISCUSSION

참고문헌 (0)

등록된 참고문헌 정보가 없습니다.

해당 권호 수록 논문 (21)

로딩중